Compound details
Gentisic acid
| Compound ID | CDAMM02906 |
|---|---|
| Common name | Gentisic acid | IUPAC name | 2,5-dihydroxybenzoic acid |
| Molecular formula | C7H6O4 |
| Retention time | 10.66 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 155.032 | Theoretical mz | 155.034 |
| Error | 12.75 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.3064 |
| Inchi key | WXTMDXOMEHJXQO-UHFFFAOYSA-N |
|---|---|
| Smiles | O=C(O)C1=CC(O)=CC=C1O |
| Superclass | Benzenoids |
| Class | Benzene and substituted derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P36544 | CHRNA7 | Neuronal acetylcholine receptor protein alpha-7 subunit | T34429 | SEA |
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SwissTargetPrediction and SEA |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SwissTargetPrediction and SEA |
| Q07820 | MCL1 | Induced myeloid leukemia cell differentiation protein Mcl-1 | T14912 | SEA |
| Q8TDS4 | HCAR2 | Hydroxycarboxylic acid receptor 2 | T88185 | SEA |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction and SEA |
| P02766 | TTR | Transthyretin | T86462 | SEA |
| P05067 | APP | Beta amyloid A4 protein | T87024 | SEA |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction and SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SwissTargetPrediction and SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SwissTargetPrediction and SEA |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SwissTargetPrediction and SEA |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SwissTargetPrediction and SEA |
| Q9H3R0 | KDM4C | Lysine-specific demethylase 4C | T73863 | SEA |
| P42330 | AKR1C3 | Aldo-keto-reductase family 1 member C3 | T60857 | SEA |
| Q6B0I6 | KDM4D | Lysine-specific demethylase 4D | T17036 | SEA |
| O75164 | KDM4A | Lysine-specific demethylase 4A | T18904 | SEA |
| Q6B0I6 | KDM4D | Lysine-specific demethylase 4D | T17036 | SEA |
| P80404 | ABAT | Gamma-amino-N-butyrate transaminase | T59045 | SEA |
| Q92731 | ESR2 | Estrogen receptor beta | T80896 | SEA |
| P07101 | TH | Tyrosine 3-hydroxylase | T62390 | SEA |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SEA |
| P03372 | ESR1 | Estrogen receptor alpha | T02506 | SEA |
| Q9Y4C1 | KDM3A | Lysine-specific demethylase 3A | T25362 | SEA |
| P16050 | ALOX15 | Arachidonate 15-lipoxygenase | T16042 | SEA |
| P24723 | PRKCH | Protein kinase C eta | T40149 | SEA |
| P08263 | GSTA1 | Glutathione S-transferase A1 | T17221 | SEA |
| Q12791 | KCNMA1 | Calcium-activated potassium channel subunit alpha-1 | T66538 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| Q9NPH5 | NOX4 | NADPH oxidase 4 | T29741 | SEA |
| P05129 | PRKCG | Protein kinase C gamma | T47107 | SEA |
| P22736 | NR4A1 | Nuclear receptor subfamily 4 group A member 1 | T41119 | SEA |
| Q15120 | PDK3 | Pyruvate dehydrogenase kinase isoform 3 | T99029 | SEA |
| Q96RR4 | CAMKK2 | CaM-kinase kinase beta | T82262 | SEA |
| P24593 | IGFBP5 | Insulin-like growth factor binding protein 5 | T17008 | SEA |
| P24592 | IGFBP6 | Insulin-like growth factor binding protein 6 | T61800 | SEA |
| P18065 | IGFBP2 | Insulin-like growth factor binding protein 2 | T64268 | SEA |
| P08833 | IGFBP1 | Insulin-like growth factor binding protein 1 | T15048 | SEA |
| P51649 | ALDH5A1 | Succinate semialdehyde dehydrogenase | T13259 | SEA |
| P09172 | DBH | Dopamine beta hydroxylase | T74937 | SEA |
| O15427 | SLC16A3 | Monocarboxylate transporter 4 | T31788 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T34429 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P36544 | CHRNA7 |
| T34429 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P36544 | CHRNA7 |
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T14912 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q07820 | MCL1 |
| T14912 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | Q07820 | MCL1 |
| T14912 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q07820 | MCL1 |
| T14912 | DI0252 | Melanoma | [ICD-11: 2C30] | Q07820 | MCL1 |
| T14912 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q07820 | MCL1 |
| T14912 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q07820 | MCL1 |
| T88185 | DI0203 | Inborn lipid metabolism error | [ICD-11: 5C52] | Q8TDS4 | HCAR2 |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T86462 | DI0026 | Amyloidosis | [ICD-11: 5D00] | P02766 | TTR |
| T87024 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P05067 | APP |
| T87024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P05067 | APP |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T60857 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P42330 | AKR1C3 |
| T59045 | DI0060 | Brain cancer | [ICD-11: 2A00] | P80404 | ABAT |
| T59045 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P80404 | ABAT |
| T59045 | DI0135 | Epileptic encephalopathy | [ICD-11: 8A62] | P80404 | ABAT |
| T59045 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P80404 | ABAT |
| T59045 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P80404 | ABAT |
| T80896 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q92731 | ESR2 |
| T80896 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | Q92731 | ESR2 |
| T80896 | DI0254 | Menopausal disorder | [ICD-11: GA30] | Q92731 | ESR2 |
| T80896 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q92731 | ESR2 |
| T62390 | DI0019 | Adrenomedullary hyperfunction | [ICD-11: 5A75] | P07101 | TH |
| T62390 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P07101 | TH |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T02506 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P03372 | ESR1 |
| T40149 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P24723 | PRKCH |
| T66538 | DI0037 | Asthma | [ICD-11: CA23] | Q12791 | KCNMA1 |
| T66538 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | Q12791 | KCNMA1 |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T29741 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | Q9NPH5 | NOX4 |
| T47107 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P05129 | PRKCG |
| T47107 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P05129 | PRKCG |
| T13259 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P51649 | ALDH5A1 |
| T13259 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P51649 | ALDH5A1 |
| T74937 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P09172 | DBH |
| T74937 | DI0341 | Post-traumatic stress disorder | [ICD-11: 6B40] | P09172 | DBH |